Investors Overview GenMark Diagnostics, Inc.

The Investor Relations website contains information about GenMark Diagnostics, Inc. business for stockholders, potential investors, and financial analysts.

OVERVIEW

This web site ir.genmarkdx.com presently has an average traffic classification of zero (the smaller the better). We have explored ten pages inside the web site ir.genmarkdx.com and found three websites associating themselves with ir.genmarkdx.com.
Pages Crawled
10
Links to this site
3

IR.GENMARKDX.COM RANKINGS

This web site ir.genmarkdx.com is seeing fluctuating amounts of traffic all round the year.
Traffic for ir.genmarkdx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.genmarkdx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.genmarkdx.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES IR.GENMARKDX.COM LOOK LIKE?

Desktop Screenshot of ir.genmarkdx.com Mobile Screenshot of ir.genmarkdx.com Tablet Screenshot of ir.genmarkdx.com

IR.GENMARKDX.COM HOST

Our parsers revealed that a single root page on ir.genmarkdx.com took three hundred and twenty-nine milliseconds to stream. I could not observe a SSL certificate, so in conclusion our parsers consider ir.genmarkdx.com not secure.
Load time
0.329 secs
SSL
NOT SECURE
Internet Protocol
23.213.123.49

WEBSITE IMAGE

SERVER OS AND ENCODING

I revealed that ir.genmarkdx.com is utilizing the nginx os.

PAGE TITLE

Investors Overview GenMark Diagnostics, Inc.

DESCRIPTION

The Investor Relations website contains information about GenMark Diagnostics, Inc. business for stockholders, potential investors, and financial analysts.

CONTENT

This web site states the following, "You are about to enter another country or region-specific website." We noticed that the web site also stated " Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site." It also said " As a result, the site may contain information on products or uses of those products that are not approved in other countries or regions. Do you wish to continue and exit this website? We have detected that you may be viewing the site from the United States."

VIEW SIMILAR BUSINESSES

Inter Resources Online timesheet management system Login

Please log in using your username and password provided by our client service team. For support relating to logins, please contact our client service team.

Gentex Corporation - Investor Relations

Annual Reports and Proxy Statements. Gentex develops high-value safety and technology products that make the world a safer, simpler, and smarter place. Gentex is committed to continuing to deliver shareholder value by developing advanced electronic products and features for the automotive, aerospace and fire protection industries.

Geron Investor Relations Overview

Investing in first-in-class cancer therapeutics. ASH 2014 Investor and Analyst Event. Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron Corporation Reports Second Quarter 2015 Financial Results. Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events.

gevo Investor Relations Investor Overview

Partnerships, Collaborations and Customer Pipeline. Gevo, ethanol and the future of biofuels. Q2 2015 Gevo, Inc. Q2 2015 Gevo, Inc. Click here to add this event to your calendar. at the Jefferies 2015 Industrials Conference. at the Jefferies 2015 Industrials Conference.